Assessment and Management of Pain in the Elderly
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Assessment of Emotional Functioning in Pain Treatment Outcome Research
Assessment of emotional functioning in pain treatment outcome research Robert D. Kerns, Ph.D. VA Connecticut Healthcare System Yale University Running head: Emotional functioning Correspondence: Robert D. Kerns, Ph.D., Psychology Service (116B), VA Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT 06516; Phone: 203-937- 3841; Fax: 203-937-4951; Electronic mail: [email protected] Emotional Functioning 2 Assessment of Emotional Functioning in Pain Treatment Outcome Research The measurement of emotional functioning as an important outcome in empirical examinations of pain treatment efficacy and effectiveness has not yet been generally adopted in the field. This observation is puzzling given the large and ever expanding empirical literature on the relationship between the experience of pain and negative mood, symptoms of affective distress, and frank psychiatric disorder. For example, Turk (1996), despite noting the high prevalence of psychiatric disorder, particularly depression, among patients referred to multidisciplinary pain clinics, failed to list the assessment of mood or symptoms of affective distress as one of the commonly cited criteria for evaluating pain outcomes from these programs. In a more recent review, Turk (2002) also failed to identify emotional distress as a key index of clinical effectiveness of chronic pain treatment. A casual review of the published outcome research in the past several years fails to identify the inclusion of measures of emotional distress in most studies of pain treatment outcome, other than those designed to evaluate the efficacy of psychological interventions. In a recent edited volume, The Handbook of Pain Assessment (Turk & Melzack, 2001), several contributors specifically encouraged inclusion of measures of psychological distress in the assessment of pain treatment effects (Bradley & McKendree-Smith, 2001; Dworkin, Nagasako, Hetzel, & Farrar, 2001; Okifuji & Turk, 2001). -
Assessment and Measurement of Pain and Pain Treatment
2 Assessment and measurement of pain and pain treatment Section Editor: Prof David A Scott 2 2.1 | Assessment Contributors: Prof David A Scott, Dr Andrew Stewart 2.2 | Measurement Contributors: Prof David A Scott, Dr Andrew Stewart 2.3 | Outcome measures in acute pain management Contributors: Prof David A Scott, Dr Andrew Stewart 5th Edition | Acute Pain Management: Scientific Evidence 3 2.0 | Assessment and measurement of pain and pain treatment Reliable and accurate assessment of acute pain is necessary to ensure safe and effective pain management and to provide effective research outcome data. The assessment and measurement of pain is fundamental to the process of assisting in the diagnosis of the cause of a patient’s pain, selecting an appropriate analgesic therapy and evaluating then modifying that therapy according to the individual patient’s response. Pain should be assessed within a sociopsychobiomedical model that recognises that physiological, psychological and environmental factors influence the overall pain experience. Likewise, the decision regarding the appropriate intervention following assessment needs to be made with regard to a number of factors, including recent therapy, potential risks and side effects, any management plan for the particular patient and the patient’s own preferences. A given pain ‘rating’ should not automatically trigger a specific intervention without such considerations being undertaken (van Dijk 2012a Level IV, n=2,674; van Dijk 2012b Level IV, n=10,434). Care must be undertaken with pain assessment to avoid the process of assessment itself acting as a nocebo (see Section 1.3). 2.1 | Assessment The assessment of acute pain should include a thorough general medical history and physical examination, a specific “pain history” (see Table 2.1) and an evaluation of associated functional impairment (see Section 2.3). -
Analgesic Policy
AMG 4pp cvr print 09 8/4/10 12:21 AM Page 1 Mid-Western Regional Hospitals Complex St. Camillus and St. Ita’s Hospitals ANALGESIC POLICY First Edition Issued 2009 AMG 4pp cvr print 09 8/4/10 12:21 AM Page 2 Pain is what the patient says it is AMG-Ch1 P3005 3/11/09 3:55 PM Page 1 CONTENTS page INTRODUCTION 3 1. ANALGESIA AND ADULT ACUTE AND CHRONIC PAIN 4 2. ANALGESIA AND PAEDIATRIC PAIN 31 3. ANALGESIA AND CANCER PAIN 57 4. ANALGESIA IN THE ELDERLY 67 5. ANALGESIA AND RENAL FAILURE 69 6. ANALGESIA AND LIVER FAILURE 76 1 AMG-Ch1 P3005 3/11/09 3:55 PM Page 2 CONTACTS Professor Dominic Harmon (Pain Medicine Consultant), bleep 236, ext 2774. Pain Medicine Registrar contact ext 2591 for bleep number. CNS in Pain bleep 330 or 428. Palliative Care Medical Team *7569 (Milford Hospice). CNS in Palliative Care bleeps 168, 167, 254. Pharmacy ext 2337. 2 AMG-Ch1 P3005 3/11/09 3:55 PM Page 3 INTRODUCTION ANALGESIC POLICY ‘Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage’ [IASP Definition]. Tolerance to pain varies between individuals and can be affected by a number of factors. Factors that lower pain tolerance include insomnia, anxiety, fear, isolation, depression and boredom. Treatment of pain is dependent on its cause, type (musculoskeletal, visceral or neuropathic), duration (acute or chronic) and severity. Acute pain which is poorly managed initially can degenerate into chronic pain which is often more difficult to manage. -
Psychological Tests Commonly Used in the Assessment of Chronic Pain *
Colorado Division of Workers’ Compensation COMPREHENSIVE PSYCHOLOGICAL TESTING Psychological Tests Commonly Used in the Assessment of Chronic Pain * TEST TEST CHARACTERISTICS STRENGTHS AND LENGTH, SCORING WEAKNESSES OPTIONS & TEST TAKING TIME Comprehensive Inventories For Medical Patients BHI™ 2 (Battery for What it Measures: Depression, anxiety and hostility; Strengths: Well-developed theoretical basis tied 217 items, 18 scales including Health Improvement – 2nd violent and suicidal ideation; borderline, emotional to a paradigm of delayed recovery in medical 3 validity measures, 40 edition ) dependency, chronic maladjustment, substance abuse, patients, and to assessing primary (“red flag”) content-based subscales, 25 history of abuse, perseverance, conflicts with and secondary (“yellow flag”) risk factors. Has critical items, 25-35 minutes, Pearson Assessments employer, family and physician, pain preoccupation, nationally normed 0-10 pain profiling. Two computerized scoring and www.pearsonassessments.c somatization, disability perceptions and others. norms groups are available, based on national report. om rehabilitation patient and community samples, Uses: Useful for identifying affective, both of which are stratified to match US census 6th grade reading level Standardization: S characterological, psychophysiological and social data. English and Spanish versions available. Scientific Review: JBG factors affecting pain and disability reports. Also Standardized audio tape administration for Intended for: M useful for assessing patients -
Assessment of Pain
ASSESSMENT OF PAIN Pediatric Pain Resource Nurse Curriculum © 2017 Renee CB Manworren, PhD, APRN, FAAN and Ann & Robert H. Lurie Children’s Hospital of Chicago. All rights reserved. Objectives • Critically evaluate pain assessment tools for reliability, validity, feasibility and utility Table of Contents for communicating pediatric patients’ pain experiences • Formulate processes and policies to ensure the organization’s pain assessment and care planning for pediatric patients is sensitive to children’s pain by acknowledging the sensory, cognitive and affective experience of pain and behavioral responses as influenced by social, cultural, spiritual and regulatory context. • Engage in pain assessment demonstrating evidence-based processes, modeling assessment principles, and using valid and reliable tools that are appropriate for the developmental level, cognitive ability, language, and care needs of pediatric patients cared for in your clinical area. page page page page page 3 8 15 17 30 Why Assess Pain in Principles of Pain Pain Assessment Process Initial Assessment Choosing Pain Children? Assessment Assessment Tools page page page page page 35 48 56 63 66 Pain Assessment Tools Assessment of Those Special Populations In Summary References for Self-report Unable to Self-report | 2 Why Assess Pain in Children? Why do you think it is Type your answer here. important to screen for and assess pain in children? | 4 Because… Assessment and treatment of pain is a fundamental human right. Declaration of Montreal , The International Association for the Study of Pain., 2011 Pain in children occurs across a spectrum of conditions including everyday pains, acute injuries and medical events, recurrent or chronic pain, and pain related to chronic or life-limiting conditions. -
Pain Module 2: Pain Assessment and Documentation Module 3: Management of Pain and Special Populations
Foundations of Safe and Effective Pain Management Evidence-based Education for Nurses, 2018 Module 1: The Multi-dimensional Nature of Pain Module 2: Pain Assessment and Documentation Module 3: Management of Pain and Special Populations Adapted from: Core Competencies for Pain Management: Results of an Inter--professional Consensus Summit: Pain Med 2013; 14(7) 971-981 Module 2: Pain Assessment and Documentation Objectives a. Understand the multidimensional features of pain assessment. b. Use valid and reliable tools for assessing pain and associated symptoms. • Initial Screening • Ongoing Assessments (Including Discharge Assessment) c. Assist patients in setting realistic acceptable pain intensity levels. d. Identify tools for assessing acute and persistent pain and for patients unable to self-report pain. e. Discuss the importance of empathic and compassionate communication during pain assessment. f. Discuss the inclusion of patient and others, in the education and shared decision-making process for pain care. ASPMN (2017-08-02). Core Curriculum for Pain Management Nursing. Elsevier Health Sciences. Patient Screening, Assessment and Management of Pain (Policy and Procedure #30327.99) A. Perform a Pain Screening during the initial assessment • Determine the presence of pain or history of persistent pain. • Identify whether the patient is opioid tolerant. B. Perform an Initial Comprehensive Pain Assessment if the Initial Pain Screening indicates pain. C. Perform Pain Screening at a frequency determined by individual patient need with consideration of patient’s condition, history, risks and treatment or procedures likely to cause pain. (Note: Assessing pain as the 5th Vital Sign is no longer a regulatory requirement) A. Perform Ongoing Pain Assessment with any report of pain and as determined by individual patient clinical condition/need. -
Practical Pain Management
PRACTICAL PAIN MANAGEMENT To start with… This is based upon various sources of information in the publications below and the way they have helped me to approach this subject. So for more information consult the following: Oxford Handbook of Palliative Care 2nd Ed: M Watson et al: Oxford University Press publications Symptom Management in Advanced Cancer 4th Ed: R Tywcross et al: PalliativeDrugs.com publications Palliative Care Formulary 4th Ed: R Twycross et al: PalliativeDrugs.com publications Drugs in Palliative Care 2nd: Andrew Dickman: Oxford University Press publications INTRODUCTION “Think Holistically” (see Figs 1-4) Remember - two important principles of palliative care are that all care should be: o PATIENT-CENTRED – putting patients & their significant others at the centre of healthcare o HOLISTIC – a healthcare approach where considering all aspects relevant to a person’s care [ie making up ‘the whole’ person] is more beneficial to the person than just focusing one of the aspects [eg. those most familiar to a healthcare worker of a particular discipline – ie doctors can focus on physical aspects alone] NB: This approach is not unique to palliative care and is seen in other disciplines eg. general practice Palliative care is holistic in the broadest extent: o The Patient: holistic by considering the physical, psychological, spiritual & social aspects relevant to the person (fig.1) which also means considering ‘The Triangle of Significant Others’ – family, carers & significant others (fig.2) o The Team: holistic in palliative care because of the fully multidisciplinary team approach It may be helpful to understand the extent of this holistic assessment by considering the following diagrams: o Fig. -
Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management
Health Care Guideline Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management How to Cite this Document Hooten M, Thorson D, Bianco J, Bonte B, Clavel Jr A, Hora J, Johnson C, Kirksson E, Noonan MP, Reznikoff C, Schweim K, Wainio J, Walker N. Institute for Clinical Systems Improvement. Pain: Assess- ment, Non-Opioid Treatment Approaches and Opioid Management. Updated August 2017. ICSI Members, Sponsors and organizations delivering care within Minnesota borders, may use ICSI documents in the following ways: • ICSI Health Care Guidelines and related products (hereinafter “Guidelines”) may be used and distributed by ICSI Member and Sponsor organizations as well as organizations delivering care within Minnesota borders. The guidelines can be used and distributed within the organization, to employees and anyone involved in the organization’s process for developing and implementing clinical guidelines. • ICSI Sponsor organizations can distribute the Guidelines to their enrollees and those care delivery organizations a sponsor holds insurance contracts with. • Guidelines may not be distributed outside of the organization, for any other purpose, without prior written consent from ICSI. • The Guidelines may be used only for the purpose of improving the health and health care of Member’s or Sponsor’s own enrollees and/or patients. • Only ICSI Members and Sponsors may adopt or adapt the Guidelines for use within their organizations. • Consent must be obtained from ICSI to prepare derivative works based on the Guidelines. • Appropriate attribution must be given to ICSI on any and all print or electronic documents that reference the Guidelines. All other copyright rights for ICSI Health Care Guidelines are reserved by the Institute for Clinical Systems Improvement. -
Neuropathic Pain
www.bpac.org.nz keyword: neuropathic Pharmacological management of neuropathic pain Diagnosing neuropathic pain Pharmacological treatment Neuropathic pain is often described in the following A different analgesic ladder is used for neuropathic pain. terms: Adjuvants ▪ Burning Adjuvants can be continued through the pain ladder. ▪ Shooting Examples are capsaicin cream and local anaesthetic ▪ Stabbing gels. ▪ Lancinating Step one: Paracetamol It is classically associated with sensory changes to the Regular use of paracetamol is introduced first and is skin, either numbness or hypersensitivity (this may include recommended at every step of the pain ladder. allodynia – sensation of pain from light touch). There may also be visible autonomic changes (e.g. altered colouring or temperature of skin, sweating) or signs of motor damage Step two: Add a TCA (e.g. muscle wasting). Tricyclic antidepressants (TCAs) are usually prescribed at night as their sedative effects may assist sleep. Neuropathic pain may be caused by damage to central, Nortriptyline may be preferable due to its fewer adverse peripheral or autonomic nerves. effects, particularly in elderly people. Initial doses of TCAs are usually low, however doses can be increased to antidepressant level, if tolerated. BPJ | Issue 16 | 13 Neuropathic pain ladder STEP 1 STEP 2 STEP 3 Add or change to Add Anti-convulsant TCA Paracetamol Adjuvant treatment TCA dosing e.g. nortriptyline: titrate up from 10mg daily Step three: Add or change to an anticonvulsant until pain settles. Carbamazepine, sodium valproate and gabapentin are all Prescribe nortriptyline 10mg tablets. Increase the effective in treating neuropathic pain. dose as directed. Supply 70 tablets. Traditionally carbamazepine is the first choice but it Patient information: The dose may be increased as follows must be titrated very slowly to avoid side effects such as until the pain settles – Take one tablet (10mg) at night for nausea, vomiting and dizziness. -
An Overview of Current Drug Advancement for Acute and Chronic Pain
Open Access Austin Pain & Relief Mini Review An Overview of Current Drug Advancement for Acute and Chronic Pain Singh US* Department of Pharmaceutical and Biomedical Sciences, Abstract The University of Georgia, USA This short review focuses on medication for the management of pain along *Corresponding author: Uma S. Singh, Department with guidelines for the use of the prescribed medicines. WHO has suggested the of Pharmaceutical and Biomedical Sciences, College of pain ladder for the management of the acute and chronic pain. The use of the Pharmacy, The University of Georgia, Athens, GA 30602, non-opioid and opioids are reviewed. Also, the use of acetaminophen together USA with non-selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and COX-2 selective are described. Several other medicines which were originally invented Received: October 04, 2016; Accepted: November 03, for the cure of other diseases, but now they are well employed for pain treatment. 2016; Published: November 04, 2016 The anticonvulsant, gabapentin and pregabalin are in use for treatment of active pain. In the same way, for the treatment of osteoporosis, calcitonin was initially discovered but now it is in widely use for management of pain. The anesthetic ketamine is also used to treat pain. For the topical treatment, Lidocaine and capsaicin patches are being used to cure the localized pain. The applications of localized patches also help to avoid the maximum systemic adverse effect. Overall several drugs are being used for the treatment of the pain with the multi- component approaches for the acute and chronic pain relief. Keywords: Pain management; Opioids; Pain ladder; Analgesics Introduction start the oral administration of the drug with Non-Steroidal Anti- Inflammatory Drugs (NSAIDS) including COX-2 inhibitors for pain It is always a challenging task for a medical practitioner to relief [7]. -
Assessing a Child's Pain
1.5 HOURS CE Continuing Education Assessing a Child’s Pain A review of tools to help evaluate pain in children of all ages and levels of cognitive development. ABSTRACT: Effective pain assessment is a necessary component of successful pain management and the pursuit of optimal health outcomes for patients of all ages. In the case of children, accurate pain assessment is particularly important, because children exposed to prolonged or repeated acute pain, including proce- dural pain, are at elevated risk for such adverse outcomes as subsequent medical traumatic stress, more in- tense response to subsequent pain, and development of chronic pain. As with adults, a child’s self-report of pain is considered the most accurate and reliable measure of pain. But the assessment of pain in children is challenging, because presentation is influenced by developmental factors, and children’s responses to certain features of pain assessment tools are unlike those commonly observed in adults. The authors describe the three types of assessment used to measure pain intensity in children and the tools developed to address the unique needs of children that employ each. Such tools take into account the child’s age as well as special circumstances or conditions, such as ventilation requirements, cognitive impair- ment, and developmental delay. The authors also discuss the importance of proxy pain reporting by the par- ent or caregiver and how nurses can improve communication between the child, caregiver, and health care providers, thereby promoting favorable patient outcomes. Keywords: assessment tools, children, pain assessment, pain measurement, pediatric pain ain is a common symptom seen in patients of in children who undergo “posttraumatic growth” all ages and in all health care settings. -
Chronic Pain Ladder
PAIN LADDER - CHRONIC PAIN Pain treatment pathway for non-cancer chronic pain ≥ 3 months duration in adults in primary care1,2,3,4 Key Principles • Consider early referral to West Suffolk Pain Service Single Point of Access in patients with excessive, uncontrolled or rapid escalating opioid requirements, and/or significant pain preventing sleep, function or work, or causing distress • Progressing through the steps below does not guarantee increased benefit or better pain relief. Medication does not always work; stop medicines that are not working. • 3-monthly medication reviews are recommended for all patients taking regular analgesics; prioritise Polypharmacy Medication Reviews for patients taking opioids or gabapentinoids STEP 1 Assessment and non pharmacological strategies • Exclude red flags. Assess pain/impact and yellow flags • Consider possibility of neuropathic/mixed pain: neuropathic pain ladder • Establish expectations and agreed goals • Discuss non pharmacological strategies and provide signposting information • Consider referral to: Wellbeing Service, physiotherapy, gentle exercise/weight loss programmes or TENS STEP 2 Paracetamol oral/rectal 1g qds (1g tds if < 50 kg, malnourished, renal or hepatic impairment) Paracetamol alone is not recommended management for low back pain 3 + / OR Ibuprofen oral 400 mg tds /topical 5% gel tds OR Naproxen oral 250-500 mg bd NSAID at lowest effective dose for shortest period. Consider a PPI. Consider possibility of neuropathic/mixed pain; refer to neuropathic pain ladder Ineffective or not tolerated: STOP Partially effective: consider adding STEP 3 Codeine oral 15-60 mg qds Avoid if breast feeding or if patient has experienced excessive response to codeine previously* OR Tramadol oral 50-100 mg qds OR Meptazinol oral 200 mg 3-6 hourly Consider referral to West Suffolk Pain Service Single Point of Access.